Hot Life Sciences Companies To Invest In 2015

With shares of�Corning Inc.�(NYSE:GLW) trading at around $16.35, is GLW an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

C = Catalyst for the Stock�� Movement

Corning has been making new 52-week highs as of late, but is this trend sustainable? In this stock market environment, anything is possible. However, that doesn�� mean all moves are justifiable.

Corning Incorporated produces and sells specialty glasses, ceramics, and related materials worldwide. It operates through five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences.

Corning has a diverse revenue base. There is currently high demand for tablets and smartphones, Gorilla Glass has received many positive reviews, Q1 estimates were recently beat, there have been cost and efficiency improvements, revenue has increased for three consecutive years, and the stock is at a good valuation, trading at 14 times earnings, while the industry trades at 19 times earnings. However, when you look at the breakdown for the last quarter, there is good reason for caution. The only segment that showed improvement was Life Sciences. Corning is confident in future growth, but that doesn�� mean confidence will lead to actual results.

Hot Heal Care Companies To Own In Right Now: Johnson Controls Inc.(JCI)

Johnson Controls, Inc. engages in building efficiency, automotive experience, and power solutions businesses worldwide. Its building efficiency business designs, produces, markets, and installs integrated heating, ventilating, and air conditioning systems, as well as building management systems, controls, and security and mechanical equipment. This business also provides technical services, energy management consulting, and operations of real estate portfolios for the non-residential buildings market. In addition, this business offers residential air conditioning and heating systems, and industrial refrigeration products. The company?s automotive experience business designs and manufactures interior products and systems for passenger cars and light trucks, including vans, pick-up trucks, and sport/crossover utility vehicles. It offers seating systems and components; cockpit systems comprising instrument panels and clusters, information displays, and body controllers; overh ead systems, such as headliners and electronic convenience features; floor consoles; and door systems. This business also produces automotive interior systems for original equipment manufacturers. Its power solutions business produces lead-acid automotive batteries serving automotive original equipment manufacturers and the general vehicle battery aftermarket. This business produces lead-acid batteries, as well as offers absorbent glass mat and lithium-ion battery technologies to power hybrid vehicles. The company was formerly known as Johnson Electric Service Company and changed its name to Johnson Controls, Inc. in 1974. Johnson Controls, Inc. was founded in 1885 and is headquartered in Milwaukee, Wisconsin.

Advisors' Opinion:

• [By Dan Caplinger]

  But the big problem for Magna has come from Europe. Rival Johnson Controls (NYSE: JCI  ) , which gets more of its revenue from Europe than from North America, has seen poor conditions in Europe weigh on its overall results. That's consistent with the big problems that major customers Ford (NYSE: F  ) and General Motors (NYSE: GM  ) have seen in their own European sales figures, with Ford having lost $1.75 billion last year in Europe and expecting that figure to balloon upward to $2 billion for 2013. Although GM managed to reduce its European losses in the first quarter to just $175 million, both it and Ford have a lot of work to do in order to get their operations on the continent back to profitability.

• [By Aimee Duffy]

  Johnson Controls (NYSE: JCI  ) employs 25,000 people in China, and it was recently one of only 36 companies to be voted a "Top Employer" by the Corporate Research Foundation. Obscure awards aside, the company has a big-time opportunity in China and investors stand to benefit handsomely.�

Hot Life Sciences Companies To Invest In 2015: Brown & Brown Inc. (BRO)

Brown & Brown, Inc., a diversified insurance agency, engages in the marketing and sale of insurance products and services in the United States. Its Retail division provides insurance products and services to commercial, public and quasi-public entity, professional, and individual customers. This division offers property insurance relating to physical damage to property, and resultant interruption of business or extra expense caused by fire, windstorm, or other perils; casualty insurance relating to legal liabilities, workers� compensation, and commercial and private passenger automobile coverage; fidelity and surety bonds; group and individual life, accident, disability, health, hospitalization, medical, and dental insurance, as well as provides risk management and loss control surveys and analysis, and consultation services. The company�s National Programs division offers professional liability and related package insurance products for dentists, lawyers, accountants, o ptometrists, opticians, insurance agents, financial service representatives, benefit administrators, real estate brokers, real estate title agents, and escrow agents. This division also markets its products and services to specific industries, trade groups, public and quasi-public entities, and market niches through independent agents. The company�s Wholesale Brokerage division markets and sells excess and surplus commercial insurance products and services to retail insurance agencies; and reinsurance products and services to insurance companies. Its Services division offers insurance-related services, including third-party claims administration and comprehensive medical utilization management services for the workers� compensation and various liability arenas; medicare set-aside services; and social security disability and medicare benefits advocacy services. Brown & Brown, Inc. was founded in 1939 and is headquartered in Daytona Beach, Florida.

Advisors' Opinion:

• [By WWW.GURUFOCUS.COM]

  We also added a new position in insurance broker Brown & Brown (BRO) when the stock fell below $29 in February. The company's business model generates high operating margins and strong free cash flow. We expect management to remain disciplined acquirers of culturally compatible companies. In the meantime, Brown & Brown would benefit from an increase in insurable exposure units in the middle-market economy. Said more simply, as "Main Street" recovers, Brown & Brown should do well.From Wallace Weitz (Trades, Portfolio)'s first quarter 2014 report.Also check out: Wallace Weitz Undervalued Stocks Wallace Weitz Top Growth Companies Wallace Weitz High Yield stocks, and Stocks that Wallace Weitz keeps buying Currently 0.00/512345

  Rating: 0.0/5 (0 votes)

• [By Eric Volkman]

  Brown & Brown's� (NYSE: BRO  ) �Q1 results have been released. For the quarter, net profit notched a new quarterly record at just over $60 million ($0.41 per diluted share), up 22% from the $49 million ($0.34) in the same period the previous year. Total revenue also improved over that time frame, coming in at $335 million against Q1 2012's figure of $302 million.

Hot Life Sciences Companies To Invest In 2015: Interleukin Genetics Inc (ILIU.PK)

Interleukin Genetics, Inc., incorporated on March 28, 2000, is a personalized health company, which develops genetic tests to provide information to manage health and specific health risks. The Company�� business focuses on personalized health, by providing genetic tests with clinical value. Its tests are made available through marketing partners or directly to end users. The Company's primary business focus and strategy is to continue the Company's commercialization efforts with its PST genetic test. In addition, the Company plans to continue to develop and sells tests for its own business needs under the Inherent Health brand.

The Company's genetic tests that are being commercialized includes PST is a genetic test, which analyzes genetic variations associated with inflammation and identifies individuals who are at increased risk for more severe periodontal disease; Weight Management Genetic Test determines whether a low fat, low carbohydrate or balanced diet may normal or vigorous exercise, which is needed to lose existing body fat; Bone Health Genetic Test is designed to identify whether an individual is more likely to be susceptible to spine fractures and low bone mineral density associated with osteoporosis; Heart Health Genetic Test is designed to identify genetic predisposition to excess inflammation, which is a risk factor for heart attack, and Wellness Select Genetic Test allows buyers to purchase any combination of Inherent Health genetic tests at a discounted price. The Company is also focusing its genetic test development efforts on the development of an Osteoarthritis, or OA, genetic test to identify individuals at increased risk for severe OA.

Genetic Test for Risk of Periodontal Disease

PST is a genetic test that analyzes genetic variations associated with inflammation and identifies individuals who are at increased risk for more severe periodontal disease. The PST genetic test identifies specific polymorphisms (genetic variations) in genes that! regulate the production of interleukin cytokines.Interleukin-1 (IL-1) is well-established as one of the critical regulators of periodontal disease, and studies in non-human primates have shown that drugs specifically blocking IL-1 alone or IL-1 plus TNFa reduces tissue destruction even when the bacterial challenge is not reduced.

Inherent Health Brand of Genetic Tests

The Company's Weight Management Genetic Test helps take the guesswork out of finding an effective diet and exercise solution by revealing actionable steps to achieve weight goals based on genetics. The test provides new information beyond traditional assessments, so that nutritional intake and fitness routines can be tailored for improved, sustainable results. This test identifies five SNPs in four human genes: fatty acid binding protein 2 (FABP2); adrenergic receptor beta 2 (ADRB2 two variations); adrenergic receptor beta 3 (ADRB3); and peroxisome proliferator-activated receptor gamma (PPAR- ). These markers are involved in certain physiological pathways relating to body weight. Certain patterns of markers are associated with differential response to certain diet and exercise regimens.

The Company has conducted a number of studies that demonstrate a gene-diet interaction based on the multi-locus patterns . In the original study, 311 overweight/obese (body mass index, 27-40 kg/m2), nondiabetic, premenopausal, generally healthy women were randomly assigned for 12 months to either the Atkins-like ( low carbohydrate), Zone-like (low carbohydrate), LEARN-like (balanced), or Ornish-like (low fat) diets for the primary purpose of losing weight. The data collected in that study included dietary intake assessment (three unannounced 24-hour recalls for each time point administered by a dietitian and analyzed using NDS-R, University of Minnesota), anthropometric measures including weight, and related physiological variables, all collected at baseline, two, six, and 12 months.

Bone Health Genetic T! est

The Company's Bone Health Genetic Test is designed to identify whether an individual is more likely to be susceptible to spine fractures and low bone mineral density associated with osteoporosis. Although it typically starts later in life, early intervention can help prevent osteoporosis. Preventive measures can reduce the risk for bone loss and fractures, which in the case of vertebral fractures leads to a hunched over appearance. The test identifies a SNP in each of three genes involved in processes that affect bone; estrogen receptor alpha (ER1 Xba1), vitamin D receptor (VDR), and interleukin-1 (IL-1). Certain patterns of variations are associated with increased risk of spine fracture and/or low bone mineral density. The test can be used as an aid to making diet, exercise, and other lifestyle choices to maintain and improve bone health.

Nutritional Needs Genetics Test

The Company's Nutritional Needs Genetics Test is designed to identify DNA variations in genes crucial to B-vitamin metabolism and the ability to manage oxidative stress. Individuals with certain variations in these genes may be at increased risk for ineffective utilization of B-vitamins and potential for cell damage caused by oxidative stress, both of which can in some cases lead to increased risk for certain diseases. The test identifies the presence or absence of human genotypic markers methylenetetrahydrofolate reductase (MTHFR) and transcobalamin II (TCN2) involved in vitamin B metabolism and markers superoxide dismutase 2 (SOD2), glutathione S-transferase 1 deletions (GSTM1), paraoxonase 1 (PON1), X-ray repair cross complementing group 1 (XRCC1) in response to oxidative stress. Certain variations are associated with less efficient B-vitamin metabolism or reduced activity of endogenous anti-oxidant systems. The test may be used to aid individuals in deciding whether to supplement their diet with B vitamins and/or antioxidants.

Genetic Test Pipeline

The Company is focusing! its gene! tic test development efforts on programs, including Osteoarthritis Genetic Test. OA is the common adult joint disease, increasing in frequency and severity in all aging populations. The estimated U.S. prevalence is 20-40 million patients or five times that of rheumatoid arthritis. The Company's OA program plans to investigate whether interleukin gene variations together with several other inflammatory gene variations is associated with the occurrence of multi-joint OA for the development of a genetic risk assessment test.

Advisors' Opinion:

• [By Brian Marckx]

  Interleukin Genetics, Inc. (ILIU.PK) develops genetic tests focused on personal health. Through applied genetics research and scientific collaborations, the company has made significant progress in understanding how genetic make-up can affect an individual's predisposition and risk of suffering from certain diseases. Interleukin's research has specifically focused on a form of genetic variation called single nucleotide polymorphisms (SNP) and how it can have an impact on a person's health. The company has applied this knowledge in the development of genetic tests focused on areas such as weight management, cardiovascular health and periodontal disease. Interleukin sells its Inherent Health line of tests, which launched in 2009, to the consumer market and maintains a CLIA-certified lab at its headquarters in Waltham, Massachusetts, where consumers send test samples for processing.

Hot Life Sciences Companies To Invest In 2015: Lindsay Corp (LNN)

Lindsay Corporation incorporated on January 7, 1974, is a provider of range of water management and road infrastructure products and services. The Company operates in two segments: Irrigation and Infrastructure. The Company�� irrigation segment includes the manufacture and marketing of center pivot, lateral move, and hose reel irrigation systems, which are used principally in the agricultural industry. The irrigation segment also manufactures and markets repair and replacement parts for its irrigation systems and controls, and designs, manufactures and services water pumping stations and controls for the agriculture, golf, landscape and municipal markets. The Company�� infrastructure segment includes the manufacture and marketing of moveable barriers, specialty barriers, crash cushions and end terminals, road marking and road safety equipment, large diameter steel tubing, railroad signals and structures, and outsourced manufacturing services. The Company�� principal infrastructure manufacturing facilities are located in Rio Vista, California, Milan, Italy, and Omaha, Nebraska. In August 2013, the Company announced that it has completed the acquisition of Claude Laval Corp.

Irrigation Segment

The Company manufactures and markets its center pivot and lateral move irrigation systems in the United States and internationally under its Zimmatic brand. The Company also manufactures and markets separate lines of center pivot and lateral move irrigation equipment for use on smaller fields under its Greenfield and hose reel travelers under the Perrot and Greenfield brands in Europe and South Africa. The Company also produces or markets irrigation controls, chemical injection systems and remote monitoring and control systems, which it sells under its GrowSmart brand. In addition to whole systems, the Company manufactures and markets repair and replacement parts for its irrigation systems and controls. The Company also designs, manufactures and services water pumping stations and! controls for the agriculture, golf, landscape and municipal markets.

The Company�� irrigation systems are primarily of the standard sized center pivot type, with a small portion of its products consisting of the lateral move type. Both are automatic, continuous move systems consisting of sprinklers mounted on a water carrying pipeline, which is supported approximately 11 feet off the ground by a truss system suspended between moving towers. The Company also manufactures and distributes mini-pivots and hose reel travelers. The Company also markets pivot monitoring and control systems, which include remote telemetry and a Web or personal computer-hosted data acquisition and monitoring application. These systems allow growers to monitor their pivot system, accumulate data on the operation of the system, and control the pivot from a remote location by logging onto an Internet Website. The pivot monitoring and control systems are marketed under the GrowSmart brand and product name FieldNET.

In the United States, the Company sells its irrigation systems, including Zimmatic, to over 200 independent dealer locations, who resell to their customer, the farmer. Dealers assess their customer�� requirements, assemble and erect the system in the field, and provide additional system components, primarily relating to water supply (wells, pumps, pipes) and electrical supply (on-site generation or hook-up to power lines). Lindsay dealers generally are local agribusinesses, many of which also deal in related products, such as well drilling and water pump equipment, farm implements, grain handling and storage systems, and farm structures. The Company has production and sales operations in France, Brazil and China, as well as distribution and sales operations in South Africa, Australia and New Zealand and sales operations in Central America and the Middle East serving the European, South American, Chinese, African, Australian, New Zealand, Central American and Middle Eastern markets, respect! ively.

Infrastructure Segment

The Company�� Quickchange Moveable Barrier (QMB) system consists of three parts: T-shaped concrete barriers that are connected to form a continuous wall; a Barrier Transfer Machine (BTM), capable of moving the barrier laterally across the pavement, and the variable length barriers necessary for accommodating curves. The BTM employs an inverted S-shaped conveyor mechanism that lifts the barrier, moving it laterally before setting it back on the roadway surface. The QMB system is useful in busy commuter corridors and at choke points, such as bridges and tunnels. QMB systems can also be deployed at roadway or roadside construction. The Company offers a range of equipment lease options for QMB systems and BTM equipment used in construction applications.

The Company offers a line of redirective and non-redirective crash cushions, which are at locations, such as toll booths, freeway off-ramps, medians and roadside barrier ends, bridge supports, utility poles and other fixed roadway hazards. The Company�� primary crash cushion products cover a range of lengths, widths, speed capacities and application accessories and include brand names, such as TAU, Universal TAU-II, TAU-B_NR, ABSORB 350 and Walt. In addition to these products the Company also offers guardrail end terminal products such as the X-Tension and TESI systems. The Company also offers specialty barrier products, such as the SAB, ArmorGuard, PaveGuard and DR46 portable barrier and/or barrier gate systems. The gates are generally used to create openings in barrier walls of various types for both construction and incident management purposes. The DR46 is an energy absorbing barrier to shield motorcyclists from impacting guardrail posts.

The Company offers preformed tape and a line of road safety accessory products. The preformed tape is used primarily in temporary applications, such as markings for work zones, street crossings, and road center lines or boundaries. The road s! afety equ! ipment consists of plastic and rubber products used for delineation, slowing traffic, and signaling. The Company also manages a testing laboratory, Safe Technologies, Inc., that performs testing of safety products. The Company�� Diversified Manufacturing and Tubing business unit (Diversified Manufacturing) manufactures and markets large diameter steel tubing and railroad signals and structures, and provides outsourced manufacturing and production services for other companies. The Company�� customer base includes certain industrial companies and railroads. The Company�� primary infrastructure market includes moveable concrete barriers, delineation systems, guardrails and similar protective equipment. The United States roadway infrastructure market includes projects, such as new roadway construction, bridges, tunnels, maintenance and resurfacing, and the purchase of rights-of-way for roadway expansion and development of technologies for relief of roadway congestion.

Advisors' Opinion:

• [By John Kell var popups = dojo.query(".socialByline .popC"); popups.forEach(func]

  Lindsay Corp.(LNN) said fiscal second-quarter revenue and earnings fell as the company’s irrigation business remains mired in a sales slump. The company’s results underperformed Wall Street expectations.

• [By Benjamin Shepherd]

  Steve Halpern: Now, one investment idea in the sector that you like is the area of water management. Could you tell us about Lindsay Corp. (LNN)?

• [By Jacob Roche]

  In 2008, only about 14% of cropland in the U.S. was irrigated, and less than half of that was done with high-efficiency center pivot systems, like the kind Valmont and its competitor Lindsay (NYSE: LNN  ) sell, so farmers have been scrambling to upgrade their equipment to deal with increasingly bad weather. This presents a big opportunity for Valmont, which gets about 28% of sales from irrigation equipment. The opportunity is even bigger for Lindsay, which gets about two-thirds of its sales from irrigation equipment.